184 related articles for article (PubMed ID: 18452169)
1. Functional evidence implicating S100P in prostate cancer progression.
Basu GD; Azorsa DO; Kiefer JA; Rojas AM; Tuzmen S; Barrett MT; Trent JM; Kallioniemi O; Mousses S
Int J Cancer; 2008 Jul; 123(2):330-339. PubMed ID: 18452169
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer.
Hammacher A; Thompson EW; Williams ED
Int J Biochem Cell Biol; 2005 Feb; 37(2):442-50. PubMed ID: 15474988
[TBL] [Abstract][Full Text] [Related]
3. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
Ling YX; Tao J; Fang SF; Hui Z; Fang QR
Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
[TBL] [Abstract][Full Text] [Related]
5. S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.
Hsu YL; Hung JY; Liang YY; Lin YS; Tsai MJ; Chou SH; Lu CY; Kuo PL
Oncotarget; 2015 Oct; 6(30):29585-98. PubMed ID: 26320193
[TBL] [Abstract][Full Text] [Related]
6. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
[TBL] [Abstract][Full Text] [Related]
7. [Biological implications of the inhibition of survivin by RNA interference in human androgen-independent prostate carcinoma with highly metastatic potential].
Zhu X; Ning JY; You JF; Wang JL; Cui XL; Fang WG; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):549-54. PubMed ID: 17134550
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of S100P by lentiviral-mediated RNAi promotes apoptosis and suppresses the colony-formation ability of gastric cancer cells.
Zhang Q; Hu H; Shi X; Tang W
Oncol Rep; 2014 May; 31(5):2344-50. PubMed ID: 24677114
[TBL] [Abstract][Full Text] [Related]
9. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid receptor-mediated transcriptional activation of S100P gene coding for cancer-related calcium-binding protein.
Tothova V; Isola J; Parkkila S; Kopacek J; Pastorek J; Pastorekova S; Gibadulinova A
J Cell Biochem; 2011 Nov; 112(11):3373-84. PubMed ID: 21751241
[TBL] [Abstract][Full Text] [Related]
11. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation and functional implication of S100P in cancer.
Gibadulinova A; Tothova V; Pastorek J; Pastorekova S
Amino Acids; 2011 Oct; 41(4):885-92. PubMed ID: 20155429
[TBL] [Abstract][Full Text] [Related]
13. Anti-Cancer Effect of α-Solanine by Down-Regulating S100P Expression in Colorectal Cancer Cells.
Ni X; Chen J; Lu F; Yuan Z; Xu X; Hu Z; Jiang L
Recent Pat Anticancer Drug Discov; 2018; 13(2):240-247. PubMed ID: 29600769
[TBL] [Abstract][Full Text] [Related]
14. Expression of S100P protein correlates with and contributes to the tumorigenic capacity of HeLa cervical carcinoma cells.
Gibadulinová A; Baráthová M; Kopácek J; Hulíková A; Pastoreková S; Kettmann R; Pastorek J
Oncol Rep; 2005 Aug; 14(2):575-82. PubMed ID: 16012747
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts.
El-Zawahry A; McKillop J; Voelkel-Johnson C
BMC Cancer; 2005 Jan; 5():2. PubMed ID: 15638938
[TBL] [Abstract][Full Text] [Related]
16. Regulation of S100P expression by androgen.
Averboukh L; Liang P; Kantoff PW; Pardee AB
Prostate; 1996 Dec; 29(6):350-5. PubMed ID: 8977631
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.
Yamasaki M; Nomura T; Sato F; Mimata H
Oncol Rep; 2007 Nov; 18(5):1145-53. PubMed ID: 17914565
[TBL] [Abstract][Full Text] [Related]
18. Expression and significance of S100P, CD147, and OCT4 in different prostate cancer tissue TNM stages.
Wang Q; Zhang JG; Wang W
Genet Mol Res; 2015 Jun; 14(2):6844-51. PubMed ID: 26125892
[TBL] [Abstract][Full Text] [Related]
19. Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysis.
Jiang L; Lai YK; Zhang J; Wang H; Lin MC; He ML; Kung HF
Mol Med; 2011; 17(7-8):709-16. PubMed ID: 21327297
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
